Is immunising all patients with chronic lung disease in the community against influenza cost effective? Evidence from a general practice based clinical prospective cohort study in Utrecht, the Netherlands

Journal of Epidemiology and Community Health

Volumn 52, Issue 2, 1998, Pages 120-125

  Hak, E ^a   Van Essen, G A ^a   Buskens, E ^b   Stalman, W ^a   De Melker, R A ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ADULT; AGED; ARTICLE; CHRONIC LUNG DISEASE; COMORBIDITY; COST EFFECTIVENESS ANALYSIS; FEMALE; GENERAL PRACTICE; HEART DISEASE; HUMAN; INFLUENZA VACCINATION; INFLUENZA VIRUS A; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NETHERLANDS; PNEUMONIA; PRACTICE GUIDELINE; REGRESSION ANALYSIS; RESPIRATORY TRACT INFECTION; SENESCENCE;

EID: 0031964139     PISSN: 0143005X     EISSN: None     Source Type: Journal    
DOI: 10.1136/jech.52.2.120     Document Type: Article

References (36)

1. Nicholson KG, Snacken R, Palache AM. Influenza immunization policies in Europe and the United States. Vaccine 1995;13:365-9.
2. Meynaar IA, Wout JW van't, Vandenbroucke JP, Furth R van. Use of influenza vaccine in The Netherlands. BMJ 1991;303:508.
3. Wiselka MJ, Kent J, Nicholson KG, Stern M. Influenza and asthma. Lancet 1992;339:367-8.
4. Fiebach N, Beckett W. Prevention of respiratory infections in adults. Arch Intern Med 1994;154:2545-57.
5. Nichol KL, Margolis KL, Lind A, et al. Side effects associated with influenza vaccination in healthy working adults. A randomised, placebo-controlled trial. Arch Intern Med 1996;156:1546-50.
6. Govaert Th ME, Dinant GJ, Aretz K, Masurel N, Sprenger MJW, Knottnerus JA. Adverse reactions to influenza vaccine in elderly people: randomised double blind placebo controlled trial. BMJ 1993;307:988-90.
7. Albazzaz MK, Harvey JE, Grilli EA, Caul EO. Subunit influenza vaccination in adults with asthma: effect on clinical state, airwayreactivity, and antibody response. BMJ 1987;294:1196-7.
8. Stenius-Aarniala B, Huttunen JK, Pyhälä R, et al. Lack of clinical exacerbations in adults with chronic asthma after immunisation with killed influenza virus. Chest 1986;89: 786-9.
9. Rothbarth PH, Kempen BM, Sprenger MJW. Sense and nonsense of influenza vaccination in asthma and chronic obstructive pulmonary disease. Am J Resp Crit Care Med 1995;151:1682-6.
10. Nichol KL, Margolis KL, Wuorenma J, Sternbcrg T von. The efficacy and cost-effectiveness of vaccination against influenza among elderly persons in the community. N Engl J Med 1994;331:778-84.
11. Mullooly JP, Bennett MD, Hornbrook MC, et al. Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization. Ann Intern Med 1994;121:947-52.
12. McBean AM, Babish JD, Warren JL. The impact and cost of influenza in the elderly. Arch Intern Med 1993;153: 2105-11.
13. Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med 1995;123:518-27.
14. Flemming DM, Watson JM, Nicholas S, Smith GE, Swan AV. Study on the effectiveness of influenza vaccination in the elderly in the epidemic of 1989-90 using a general practice database. Epidemiol Infect 1995;115:581-9.
15. Ohmit SE, Monto AS. Influenza vaccine effectiveness in preventing hospitalization among the elderly during influenza type A and type B seasons. Int J Epidemiol 1995; 24:1240-8.
16. Govaert ThME, Thijs CTMCN, Masurel N, Sprenger MJW, Dinant GJ, Knottnerus JA. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA 1994;272:1661-5.
17. Ahmed Ah, Nicholson KG, Nguyen-Van-Tam. Reduction in mortality associated with influenza vaccine during 1989-90 epidemic. Lancet 1995;346:591-5.
18. Fedson DS, Wadja A, Nicol JP, Hammond GW, Kaiser DL, Roos LL. Clinical effectiveness of influenza vaccination in Manitoba. JAMA 1993;270:1956-61
19. Riddiough MA, Sisk JE, Bell JC. Influenza vaccination. Cost-effectiveness and public policy. JAMA 1983;249: 3189-95.
20. Ong ELC. Influenza and asthma. Lancet 1992;339:367.
21. Fedson DS, Hannoun C, Leese J, et al. Influenza vaccination in 18 developed countries, 1980-1992. Vaccine 1995;13: 623-7.
22. Lamberts H, Wood M, eds. ICPC. International classification of primary care. Oxford: Oxford University Press, 1987.
23. Classification committee of WONCA. ICHPPC-2 defined. International classification of health problems in primary care. Oxford: Oxford University Press, 1983.
24. Anonymus. Anatomical Therapeutic Chemical (ATC) classification index. Oslo: WHO Collaborating Centre for Drug Statistics Methodology, 1996.
25. Hak E, Hermens RPMG van, Essen GA van, Kuyvenhoven MM, De Melker RA. Population-based prevention of influenza in Dutch general practice. Br J Gen Pract 1997;47:363-6.
26. Essen GA van, Sorgedrager YCG, Salemink GW, Govaert ThME, Hoogen JPH van den, Laan JR van der. NHG-Standaard Influenza en influenzavaccinatie. (NHG guidelines Influenza and influenza vaccination). Huisarts Wet 1993;36:342-6. (With abstract in English).
27. Beasley R, Coleman ED, Hermon Y, Holst PE, O'Donell TV, Tobias M. Viral respiratory tract infections and exacerbations of asthma in adult patients. Thorax 1988;43:679-83.
28. Claas ECJ, Jong JC de, Bartelds AIM, Rimmelzwaan GF, Wijngaarden JK van, Osterhaus ADME. Influenza in het seizoen 1995/96; vaccinsamenstelling voor het seizoen 1996/97. (Influenza in the 1995/96 season; vaccine composition for the 1996/97 season). Ned Tijdschr Geneesk 1996;140:2047-50. (With abstract in English).
29. Connolly AM, Salmon RL, Williams DH. What are the complications of influenza and can they be prevented? Experience from the 1989 epidemic of H3N2 influenza A in general practice. BMJ 1993;306:1452-4.
30. Bainton D, Jones GR, Hole D. Influenza and ischaemic heart disease- a possible trigger for acute myocardial infarction? Int J Epidemiol 1978;7:231-9.
31. Hosmer DW, Lemeshow S. Applied logistic regression. New York: John Wiley, 1989.
32. Rutten FPH, Ineveld BM van, Ommen R van, Hout BA van, Huijsman R. Kostenberekening bijgezondheidszorgonderzoek. Richtlijnen voor de praktijk. (Calculating costs in health care research. Guidelines for practical use) Utrecht: Jan Van Arkel, 1993. (In Dutch).
33. Lamberts H, Brouwer HJ, Mohrs J. Reason for encounter-, episode- and proces-oriented standard output from the Transition project. Amsterdam: Department of General Practice, University of Amsterdam, 1991.
34. Tirimanna PRS, Schayck CP van, Otter JJ den, et al. Prevalence of asthma and COPD in general practice in 1992: Has it changed since 1977? Br J Gen Pract 1996;46:277-81.
35. Perez-Tirse J, Gross PA. Review of cost-benefit analyses of influenza vaccine. PharmacoEconomics 1992;2:198-206.
36. Fleming DM, Cross KW. Respiratory syncitial virus or influenza? Lancet 1993;342:1507-9.